Asset Management One
TPST icon

Asset Management One’s Tempest Therapeutics TPST Stock Holding History

Asset Management One’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-105
Closed -$2.22M – 1198
2016
Q3 		$2.22M Sell
105
-11
-9% -$199K 0.03% 572
2016
Q2 		$1.82M Buy
116
+11
+10% +$251K 0.03% 648
2016
Q1 		$2.84M Buy
105
+4
+4% +$84.5K 0.04% 495
2015
Q4 		$2.97M Hold
101
– – 0.04% 468
2015
Q3 		$2.52M Sell
101
-18
-15% -$1.21M 0.04% 539
2015
Q2 		$9.65M Sell
119
-12
-9% -$1.1M 0.13% 193
2015
Q1 		$14.7M Buy
131
+27
+26% +$3.6M 0.18% 127
2014
Q4 		$13.9M Buy
104
+7
+7% +$513K 0.18% 132
2014
Q3 		$4.72M Buy
+97
New +$3.4M 0.07% 359

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Asset Management One's TPST Position: Q4 2016 in Review

Asset Management One sold out of Tempest Therapeutics (TPST) in Q4 2016, closing a stake of 105 shares — an estimated $2.22M sold.

Asset Management One first reported a position in TPST in Q3 2014 and held it in 9 quarters. The position peaked at $14.7M in Q1 2015. 84 funds tracked by Wall St. Rank hold TPST as of Q4 2016.

  • Asset Management One reported no remaining Tempest Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 105 Tempest Therapeutics shares in Q4 2016, an estimated $2.22M.
  • Asset Management One first reported a position in Tempest Therapeutics in Q3 2014 and held it in 9 quarters.
  • Asset Management One's Tempest Therapeutics position peaked at $14.7M in Q1 2015.
  • 84 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.